nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—DRD1—nerve—acquired immunodeficiency syndrome	0.0326	0.0803	CbGeAlD
Propiomazine—DRD2—nerve—acquired immunodeficiency syndrome	0.0193	0.0475	CbGeAlD
Propiomazine—CHRM5—skin of body—acquired immunodeficiency syndrome	0.0139	0.0343	CbGeAlD
Propiomazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.0127	0.0313	CbGeAlD
Propiomazine—DRD4—brain—acquired immunodeficiency syndrome	0.0111	0.0274	CbGeAlD
Propiomazine—CHRM4—nervous system—acquired immunodeficiency syndrome	0.011	0.0271	CbGeAlD
Propiomazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.0108	0.0267	CbGeAlD
Propiomazine—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.0106	0.0261	CbGeAlD
Propiomazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00961	0.0237	CbGeAlD
Propiomazine—CHRM5—nervous system—acquired immunodeficiency syndrome	0.00861	0.0212	CbGeAlD
Propiomazine—CHRM4—brain—acquired immunodeficiency syndrome	0.00842	0.0207	CbGeAlD
Propiomazine—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.00829	0.0204	CbGeAlD
Propiomazine—DRD2—retina—acquired immunodeficiency syndrome	0.00798	0.0197	CbGeAlD
Propiomazine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00787	0.0194	CbGeAlD
Propiomazine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.0077	0.019	CbGeAlD
Propiomazine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.00758	0.0187	CbGeAlD
Propiomazine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.00741	0.0183	CbGeAlD
Propiomazine—DRD1—nervous system—acquired immunodeficiency syndrome	0.00734	0.0181	CbGeAlD
Propiomazine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.00706	0.0174	CbGeAlD
Propiomazine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00676	0.0167	CbGeAlD
Propiomazine—CHRM5—brain—acquired immunodeficiency syndrome	0.00658	0.0162	CbGeAlD
Propiomazine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.00623	0.0153	CbGeAlD
Propiomazine—ADRA1B—brain—acquired immunodeficiency syndrome	0.00602	0.0148	CbGeAlD
Propiomazine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.00591	0.0146	CbGeAlD
Propiomazine—ADRA1D—brain—acquired immunodeficiency syndrome	0.00588	0.0145	CbGeAlD
Propiomazine—CHRM1—lung—acquired immunodeficiency syndrome	0.00581	0.0143	CbGeAlD
Propiomazine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00579	0.0143	CbGeAlD
Propiomazine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.0057	0.014	CbGeAlD
Propiomazine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.00569	0.014	CbGeAlD
Propiomazine—DRD1—brain—acquired immunodeficiency syndrome	0.00561	0.0138	CbGeAlD
Propiomazine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00549	0.0135	CbGeAlD
Propiomazine—ADRA1A—blood—acquired immunodeficiency syndrome	0.00545	0.0134	CbGeAlD
Propiomazine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00538	0.0133	CbGeAlD
Propiomazine—HTR2A—retina—acquired immunodeficiency syndrome	0.00526	0.013	CbGeAlD
Propiomazine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00518	0.0128	CbGeAlD
Propiomazine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.00482	0.0119	CbGeAlD
Propiomazine—DRD2—lung—acquired immunodeficiency syndrome	0.00468	0.0115	CbGeAlD
Propiomazine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00464	0.0114	CbGeAlD
Propiomazine—CHRM2—brain—acquired immunodeficiency syndrome	0.00452	0.0111	CbGeAlD
Propiomazine—HRH1—digestive system—acquired immunodeficiency syndrome	0.00443	0.0109	CbGeAlD
Propiomazine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.00442	0.0109	CbGeAlD
Propiomazine—HTR2C—brain—acquired immunodeficiency syndrome	0.00436	0.0107	CbGeAlD
Propiomazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.00433	0.0107	CbGeAlD
Propiomazine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00426	0.0105	CbGeAlD
Propiomazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00417	0.0103	CbGeAlD
Propiomazine—CHRM1—brain—acquired immunodeficiency syndrome	0.00411	0.0101	CbGeAlD
Propiomazine—HRH1—vagina—acquired immunodeficiency syndrome	0.00391	0.00963	CbGeAlD
Propiomazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.0037	0.0091	CbGeAlD
Propiomazine—HRH1—lung—acquired immunodeficiency syndrome	0.0037	0.0091	CbGeAlD
Propiomazine—CHRM3—brain—acquired immunodeficiency syndrome	0.00368	0.00907	CbGeAlD
Propiomazine—HTR2A—blood—acquired immunodeficiency syndrome	0.00352	0.00867	CbGeAlD
Propiomazine—HRH1—nervous system—acquired immunodeficiency syndrome	0.00342	0.00843	CbGeAlD
Propiomazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00339	0.00836	CbGeAlD
Propiomazine—ADRA1A—brain—acquired immunodeficiency syndrome	0.00338	0.00832	CbGeAlD
Propiomazine—DRD2—brain—acquired immunodeficiency syndrome	0.00331	0.00816	CbGeAlD
Propiomazine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.0033	0.00812	CbGeAlD
Propiomazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.00326	0.00804	CbGeAlD
Propiomazine—HTR2A—lung—acquired immunodeficiency syndrome	0.00309	0.0076	CbGeAlD
Propiomazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00286	0.00704	CbGeAlD
Propiomazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00275	0.00678	CbGeAlD
Propiomazine—HRH1—brain—acquired immunodeficiency syndrome	0.00262	0.00644	CbGeAlD
Propiomazine—HRH1—lymph node—acquired immunodeficiency syndrome	0.00253	0.00623	CbGeAlD
Propiomazine—HTR2A—brain—acquired immunodeficiency syndrome	0.00219	0.00538	CbGeAlD
Propiomazine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.0011	0.193	CrCbGaD
Propiomazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	0.00107	0.189	CrCbGaD
Propiomazine—Thiothixene—ALB—acquired immunodeficiency syndrome	0.00106	0.186	CrCbGaD
Propiomazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	0.00106	0.186	CrCbGaD
Propiomazine—Clomipramine—ALB—acquired immunodeficiency syndrome	0.000835	0.147	CrCbGaD
Propiomazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	0.000573	0.101	CrCbGaD
Propiomazine—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00032	0.000544	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000318	0.000541	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000317	0.00054	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000317	0.00054	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000317	0.000539	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000317	0.000538	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000317	0.000538	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000316	0.000537	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000316	0.000537	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000316	0.000537	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000316	0.000537	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000315	0.000535	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000315	0.000535	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000312	0.00053	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000312	0.00053	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000312	0.00053	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000311	0.000528	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000311	0.000528	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000307	0.000522	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000306	0.000521	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000302	0.000513	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000298	0.000507	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000297	0.000505	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000294	0.0005	CbGpPWpGaD
Propiomazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000294	0.0005	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000293	0.000498	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000293	0.000498	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000293	0.000498	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000289	0.000491	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000289	0.000491	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000282	0.000479	CbGpPWpGaD
Propiomazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000281	0.000478	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00028	0.000477	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00028	0.000477	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000278	0.000473	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000277	0.00047	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000277	0.00047	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000276	0.000469	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000274	0.000466	CbGpPWpGaD
Propiomazine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000274	0.000465	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00027	0.000459	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000268	0.000456	CbGpPWpGaD
Propiomazine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000268	0.000456	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000266	0.000453	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000266	0.000452	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000266	0.000452	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000265	0.000451	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000265	0.00045	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000265	0.00045	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000265	0.00045	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000264	0.00045	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000264	0.000449	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000264	0.000448	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000262	0.000446	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000262	0.000445	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000261	0.000444	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000261	0.000444	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000261	0.000443	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00026	0.000443	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00026	0.000441	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000257	0.000437	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000256	0.000436	CbGpPWpGaD
Propiomazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000255	0.000434	CbGpPWpGaD
Propiomazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000255	0.000433	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000254	0.000432	CbGpPWpGaD
Propiomazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000254	0.000432	CbGpPWpGaD
Propiomazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000253	0.00043	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000252	0.000429	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000252	0.000429	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000251	0.000426	CbGpPWpGaD
Propiomazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00025	0.000425	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000249	0.000423	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000249	0.000423	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000245	0.000417	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000243	0.000414	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000243	0.000413	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000242	0.000411	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000241	0.00041	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000241	0.00041	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00024	0.000408	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00024	0.000408	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00024	0.000407	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000239	0.000407	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000239	0.000406	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000238	0.000405	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000238	0.000404	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000238	0.000404	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000237	0.000403	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000237	0.000403	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000237	0.000402	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000236	0.000402	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000236	0.000401	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000235	0.0004	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000235	0.000399	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000234	0.000397	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000233	0.000396	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00023	0.00039	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000224	0.000381	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000221	0.000376	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000221	0.000375	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00022	0.000374	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00022	0.000374	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000219	0.000373	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000219	0.000372	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000218	0.00037	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000217	0.000369	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000217	0.000368	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000216	0.000368	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000216	0.000367	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000216	0.000367	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000216	0.000367	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000216	0.000367	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000214	0.000363	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000213	0.000363	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000213	0.000362	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00021	0.000358	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00021	0.000357	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000207	0.000352	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000207	0.000352	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000207	0.000351	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000207	0.000351	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000204	0.000347	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000203	0.000345	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000202	0.000343	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000199	0.000339	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000199	0.000338	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000198	0.000337	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000198	0.000337	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000198	0.000336	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000196	0.000333	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000196	0.000332	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000195	0.000332	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000192	0.000327	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000192	0.000326	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000191	0.000324	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000191	0.000324	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00019	0.000322	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000189	0.000322	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000189	0.000322	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000188	0.000319	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000187	0.000319	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000187	0.000319	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000187	0.000318	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000187	0.000318	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000187	0.000317	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000186	0.000317	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000186	0.000317	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000186	0.000317	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000186	0.000316	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000186	0.000316	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000185	0.000315	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000184	0.000313	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000184	0.000313	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000184	0.000313	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000184	0.000312	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000184	0.000312	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000182	0.000309	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000178	0.000302	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000173	0.000294	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000171	0.00029	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000169	0.000288	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000167	0.000284	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000164	0.000279	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000162	0.000275	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000159	0.000271	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000157	0.000267	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000155	0.000263	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000153	0.000259	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000148	0.000252	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000145	0.000246	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000145	0.000246	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000143	0.000243	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000143	0.000242	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000142	0.000242	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000142	0.000241	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000142	0.000241	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000141	0.00024	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000141	0.000239	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000141	0.000239	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00014	0.000238	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00014	0.000238	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00014	0.000238	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00014	0.000237	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000139	0.000237	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000139	0.000236	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000138	0.000235	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000138	0.000235	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000138	0.000235	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000138	0.000234	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000138	0.000234	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000137	0.000233	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000136	0.000231	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000136	0.00023	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000131	0.000222	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000129	0.000218	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000128	0.000218	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000128	0.000217	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000128	0.000217	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000127	0.000217	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000126	0.000214	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000126	0.000214	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000126	0.000214	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000125	0.000213	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000125	0.000213	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000125	0.000212	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000123	0.00021	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000123	0.000209	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000111	0.000189	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00011	0.000188	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00011	0.000186	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000109	0.000185	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000109	0.000185	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000105	0.000178	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000104	0.000177	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.99e-05	0.00017	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.94e-05	0.000169	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.86e-05	0.000168	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.81e-05	0.000167	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.55e-05	0.000145	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.51e-05	0.000145	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.18e-05	0.000139	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.14e-05	0.000138	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.55e-05	0.000128	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.51e-05	0.000128	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.42e-05	0.000126	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.41e-05	0.000126	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.39e-05	0.000126	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.39e-05	0.000126	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.37e-05	0.000125	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.36e-05	0.000125	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.35e-05	0.000125	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.32e-05	0.000125	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.29e-05	0.000124	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.27e-05	0.000124	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.25e-05	0.000123	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.23e-05	0.000123	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.53e-05	0.000111	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.44e-05	0.000109	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.17e-05	0.000105	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.87e-05	9.99e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.8e-05	9.85e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.03e-05	8.54e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.81e-05	8.18e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.44e-05	7.54e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.36e-05	7.42e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.35e-05	7.4e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.34e-05	7.38e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.33e-05	7.36e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.29e-05	7.28e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.27e-05	7.26e-05	CbGpPWpGaD
